葛兰素史克Glaxosmithkline plc (GSK) 2006年年度报告「LSE」.pdf

1、A humanraceAnnual Report 2006Do more,feel better,live longerFinancial summary*CER%growth is on an IFRS basis for 2006 and 2005 and a UK GAAP,business performance basis for 2004 and earlier.In order to illustrate underlying performance,it isthe Groups practice to discuss its results in terms of const

2、ant exchange rate(CER)growth.This represents growth calculated as if the exchange rates used to determinethe results of overseas companies in Sterling had remained unchanged from those used in the previous year.CER%represents growth at constant exchange rates.Sterling%or%represents growth at actual

3、exchange rates.WebsiteGlaxoSmithKlines website gives additional information on the Group.Information made available on the website does not constitute part of this Annual Report.Notice regarding limitations on Director liability under English LawUnder the UK Companies Act 2006,a new safe harbour lim

4、its the liability of Directors in respect of statements in and omissions from the Report of the Directors containedon pages 2 and 3 and 6 to 82,under English law the Directors would be liable to the company(but not to any third party)if the Report of the Directors contains errors asa result of reckl

5、essness or knowing misstatement or dishonest concealment of a material fact,but would not otherwise be liable.Report of the DirectorsPages 2 and 3 and 6 to 82 inclusive consist of a Report of the Directors that has been drawn up and presented in accordance with and in reliance upon English companyla

6、w and the liabilities of the Directors in connection with that report shall be subject to the limitations and restrictions provided by such law.Cautionary statement regarding forward-looking statementsThe Groups reports filed with or furnished to the US Securities and Exchange Commission(SEC),includ